Literature DB >> 15525275

Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice.

Mikko Airavaara1, Anu Planken, Helena Gäddnäs, Timo Petteri Piepponen, Mart Saarma, Liisa Ahtee.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has been shown to be involved in the maintenance of striatal dopaminergic neurons. To study whether reduced levels of endogenous GDNF affect the striatal dopaminergic transmission we estimated the basal extracellular levels of dopamine in vivo, the basal expression of FosB-related proteins in striatal brain areas as well as the effects of acute and repeated cocaine on locomotor activity and dopamine output in mice lacking one GDNF allele (heterozygous GDNF+/- mice). As expected the striatal GDNF protein content was found to be smaller in the GDNF+/- mice than in their wild-type littermates. Unexpectedly the extracellular dopamine concentration in the GDNF+/- mice in the dorsal striatum (CPu) was 2.0-fold, and in the nucleus accumbens (NAc) 1.6-fold the concentration found in the wild-type littermates. Also FosB/DeltaFosB-like immunoreactivity was found to be elevated in the CPu as well as in the core and in the shell of NAc of the GDNF+/- mice as compared with the wild-type mice. This suggests chronic postsynaptic activation of these brain areas and is in line with elevated extracellular dopamine concentrations. Cocaine's effects acutely and after repeated treatment on locomotor activity were similar in the GDNF+/- and the wild-type mice. Neither did cocaine's acute effects on dopamine output differ between the mice of the two strains. Our findings demonstrate that reduced levels of endogenous GDNF induce alterations in dorsal striatal and accumbal dopaminergic transmission, and stress the importance of endogenous GDNF in the regulation of the dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525275     DOI: 10.1111/j.1460-9568.2004.03700.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  24 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 2.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

3.  Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.

Authors:  Jaakko Kopra; Marian Villarta-Aguilera; Mari Savolainen; Samo Weingerl; Timo T Myöhänen; Saara Rannanpää; Michael F Salvatore; Jaan-Olle Andressoo; T Petteri Piepponen
Journal:  Neuropharmacology       Date:  2017-10-13       Impact factor: 5.250

4.  Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

Authors:  Sara af Bjerkén; Heather A Boger; Matthew Nelson; Barry J Hoffer; Ann-Charlotte Granholm; Ingrid Strömberg
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

5.  Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor.

Authors:  Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Carsten K Nielsen; Selena E Bartlett; Patricia H Janak; Dorit Ron
Journal:  Biol Psychiatry       Date:  2009-02-20       Impact factor: 13.382

6.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

Review 7.  Update of neurotrophic factors in neurobiology of addiction and future directions.

Authors:  Maryna Koskela; Susanne Bäck; Vootele Võikar; Christopher T Richie; Andrii Domanskyi; Brandon K Harvey; Mikko Airavaara
Journal:  Neurobiol Dis       Date:  2016-05-14       Impact factor: 5.996

Review 8.  GDNF--a potential target to treat addiction.

Authors:  Sebastien Carnicella; Dorit Ron
Journal:  Pharmacol Ther       Date:  2008-12-24       Impact factor: 12.310

Review 9.  A dual-hit animal model for age-related parkinsonism.

Authors:  Heather A Boger; Ann-Charlotte Granholm; Jacqueline F McGinty; Lawrence D Middaugh
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

Review 10.  Why is neuroimmunopharmacology crucial for the future of addiction research?

Authors:  Mark R Hutchinson; Linda R Watkins
Journal:  Neuropharmacology       Date:  2013-06-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.